🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07141979
Recruiting Not applicable

Effects of tDCS on Cognitive Flexibility and EEG Oscillations in Orthorexia Nervosa

NCT07141979 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-11-01
Last updated
2026-04-01

Condition(s) studied

Orthorexia Nervosa

Investigational drug(s) / intervention(s)

Active tDCSSham tDCS

Active tDCS: 20 min, 2 milliampere (mA), Anodal tDCS in left DLPFC

Sham tDCS: 20 min, left DLPFC Sham tDCS

Study summary

Orthorexia Nervosa (ON); is a condition characterized by individuals being overly focused on healthy eating habits, constantly checking and classifying the foods they will consume. ON has not yet been clinically defined as an eating disorder or in a different category, and has not been included in DSM-5. Cognitive flexibility can be defined as a person's ability to quickly change their thinking and behaviors to adapt to different situations and changing conditions. It has been reported that cognitive flexibility skills are impaired in ON. There is evidence that tDCS, a neuromodulation method, increases cognitive flexibility skills. On the other hand, although there are EEG studies on eating disorders, there is no EEG study directly studying ON, and there is no information on the EEG profiles of individuals with high ON scores. For this reason, EEG studies on eating disorders and obsessive behaviors are generally generalized to orthorexia nervosa and are interpreted. This study aims to compare the EEG oscillations and cognitive flexibility skills of individuals with high ON scores with a control group and to examine the effects of anodal tDCS application on these two variables. For this purpose, a total of 48 individuals, 24 healthy and 24 high ON scores, will be included in the study. Participants will be randomly assigned to tDCS experimental and control groups. Therefore, 48 participants will be divided into 4 different subgroups of 12 people each. Data collection tools will be Informed Consent Form, Demographic Information Form, Beck Depression Inventory, Orthorexia Nervosa Test (TON-17), Cognitive flexibility task. First, participants will be subjected to a cognitive flexibility task by taking simultaneous EEG recordings, then tDCS stimulation will be initiated (active or sham) and after stimulation, a cognitive flexibility task will be performed by taking simultaneous EEG recordings again. EEG analyses will be performed using the Brain-Vision Analyzer program. Repeated Measures Analysis of Variance (within-group and between-groups) will be used in statistical analyses.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Being between the ages of 18-40, * Having a score of 17 or less on the Beck Depression Inventory * Having a score of 61 or more on the Test for Orthorexia Nervosa (TON-17) for the orthorexia group Exclusion Criteria: * Having a history of serious neurological and psychiatric illness, * Currently taking medication that alters the cortical excitability level, * Having visual defects that cannot be corrected with glasses * Use of intracranial metal objects, implanted stimulating devices or pacemakers

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Medipol University Istanbul Turkey (Türkiye) Recruiting

More Istanbul Medipol University Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07141979 on ClinicalTrials.gov ↗ ← All trials in Turkey